Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury.

Yin, Jianyong

Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury. [electronic resource] - Journal of cellular and molecular medicine Dec 2017 - 3506-3514 p. digital

Publication Type: Journal Article

1582-4934

10.1111/jcmm.13261 doi


Actins--antagonists & inhibitors
Acute Kidney Injury--genetics
Animals
Antithrombin III--pharmacology
Collagen Type I--antagonists & inhibitors
Disease Models, Animal
Disease Progression
Fibronectins--antagonists & inhibitors
Fibrosis
Gene Expression Regulation--drug effects
Interleukin-1beta--antagonists & inhibitors
Kidney--drug effects
Macrophages--drug effects
Male
Nephrectomy
Nitric Oxide Synthase Type II--antagonists & inhibitors
Rats
Rats, Sprague-Dawley
Reperfusion Injury--genetics
Signal Transduction
Tumor Necrosis Factor-alpha--antagonists & inhibitors